Single-cell RNA-seq highlights a specific carcinoembryonic cluster in ovarian cancer
Expounding the heterogeneity for ovarian cancer (OC) with the cognition in developmental biology might be helpful to search for robust prognostic markers and effective treatments. In the present study, we employed single-cell RNA-seq with ovarian cancers, normal ovary, and embryo tissue to explore t...
Saved in:
Published in | Cell death & disease Vol. 12; no. 11; pp. 1082 - 11 |
---|---|
Main Authors | , , , , , , , |
Format | Journal Article |
Language | English |
Published |
London
Nature Publishing Group UK
13.11.2021
Springer Nature B.V Nature Publishing Group |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Expounding the heterogeneity for ovarian cancer (OC) with the cognition in developmental biology might be helpful to search for robust prognostic markers and effective treatments. In the present study, we employed single-cell RNA-seq with ovarian cancers, normal ovary, and embryo tissue to explore their heterogeneity. Then the differentiation process of clusters was explored; the pivotal cluster and markers were identified. Furthermore, the consensus clustering algorithm was used to explore the different clinical phenotypes in OC. At last, a prognostic model was construct and used to assess the prognosis for OCs. As a result, eight diverse clusters were identified, and the similarity existed in some clusters between embryo and tumours based on their gene expression. Meaningfully, a subtype of malignant epithelial cluster, PEG10
+
EME, was associated with poor survival and was an intermediate stage of embryo to tumour. PEG10 was a CSC marker and might influence CSC self-renewal and promote cisplatin resistance via NOTCH pathway. Utilising specific gene profiles of PEG10
+
EME based on public data sets, four phenotypes with different survival and clinical response to anti-PD-1/PD-L1 immunotherapy were identified. These insights allowed for the investigation of single-cell transcriptome of OCs and embryo, which advanced our current understanding of OC pathogenesis and resulted in promising therapeutic strategies. |
---|---|
AbstractList | Abstract Expounding the heterogeneity for ovarian cancer (OC) with the cognition in developmental biology might be helpful to search for robust prognostic markers and effective treatments. In the present study, we employed single-cell RNA-seq with ovarian cancers, normal ovary, and embryo tissue to explore their heterogeneity. Then the differentiation process of clusters was explored; the pivotal cluster and markers were identified. Furthermore, the consensus clustering algorithm was used to explore the different clinical phenotypes in OC. At last, a prognostic model was construct and used to assess the prognosis for OCs. As a result, eight diverse clusters were identified, and the similarity existed in some clusters between embryo and tumours based on their gene expression. Meaningfully, a subtype of malignant epithelial cluster, PEG10+ EME, was associated with poor survival and was an intermediate stage of embryo to tumour. PEG10 was a CSC marker and might influence CSC self-renewal and promote cisplatin resistance via NOTCH pathway. Utilising specific gene profiles of PEG10+ EME based on public data sets, four phenotypes with different survival and clinical response to anti-PD-1/PD-L1 immunotherapy were identified. These insights allowed for the investigation of single-cell transcriptome of OCs and embryo, which advanced our current understanding of OC pathogenesis and resulted in promising therapeutic strategies. Expounding the heterogeneity for ovarian cancer (OC) with the cognition in developmental biology might be helpful to search for robust prognostic markers and effective treatments. In the present study, we employed single-cell RNA-seq with ovarian cancers, normal ovary, and embryo tissue to explore their heterogeneity. Then the differentiation process of clusters was explored; the pivotal cluster and markers were identified. Furthermore, the consensus clustering algorithm was used to explore the different clinical phenotypes in OC. At last, a prognostic model was construct and used to assess the prognosis for OCs. As a result, eight diverse clusters were identified, and the similarity existed in some clusters between embryo and tumours based on their gene expression. Meaningfully, a subtype of malignant epithelial cluster, PEG10 EME, was associated with poor survival and was an intermediate stage of embryo to tumour. PEG10 was a CSC marker and might influence CSC self-renewal and promote cisplatin resistance via NOTCH pathway. Utilising specific gene profiles of PEG10 EME based on public data sets, four phenotypes with different survival and clinical response to anti-PD-1/PD-L1 immunotherapy were identified. These insights allowed for the investigation of single-cell transcriptome of OCs and embryo, which advanced our current understanding of OC pathogenesis and resulted in promising therapeutic strategies. Expounding the heterogeneity for ovarian cancer (OC) with the cognition in developmental biology might be helpful to search for robust prognostic markers and effective treatments. In the present study, we employed single-cell RNA-seq with ovarian cancers, normal ovary, and embryo tissue to explore their heterogeneity. Then the differentiation process of clusters was explored; the pivotal cluster and markers were identified. Furthermore, the consensus clustering algorithm was used to explore the different clinical phenotypes in OC. At last, a prognostic model was construct and used to assess the prognosis for OCs. As a result, eight diverse clusters were identified, and the similarity existed in some clusters between embryo and tumours based on their gene expression. Meaningfully, a subtype of malignant epithelial cluster, PEG10+ EME, was associated with poor survival and was an intermediate stage of embryo to tumour. PEG10 was a CSC marker and might influence CSC self-renewal and promote cisplatin resistance via NOTCH pathway. Utilising specific gene profiles of PEG10+ EME based on public data sets, four phenotypes with different survival and clinical response to anti-PD-1/PD-L1 immunotherapy were identified. These insights allowed for the investigation of single-cell transcriptome of OCs and embryo, which advanced our current understanding of OC pathogenesis and resulted in promising therapeutic strategies. Expounding the heterogeneity for ovarian cancer (OC) with the cognition in developmental biology might be helpful to search for robust prognostic markers and effective treatments. In the present study, we employed single-cell RNA-seq with ovarian cancers, normal ovary, and embryo tissue to explore their heterogeneity. Then the differentiation process of clusters was explored; the pivotal cluster and markers were identified. Furthermore, the consensus clustering algorithm was used to explore the different clinical phenotypes in OC. At last, a prognostic model was construct and used to assess the prognosis for OCs. As a result, eight diverse clusters were identified, and the similarity existed in some clusters between embryo and tumours based on their gene expression. Meaningfully, a subtype of malignant epithelial cluster, PEG10 + EME, was associated with poor survival and was an intermediate stage of embryo to tumour. PEG10 was a CSC marker and might influence CSC self-renewal and promote cisplatin resistance via NOTCH pathway. Utilising specific gene profiles of PEG10 + EME based on public data sets, four phenotypes with different survival and clinical response to anti-PD-1/PD-L1 immunotherapy were identified. These insights allowed for the investigation of single-cell transcriptome of OCs and embryo, which advanced our current understanding of OC pathogenesis and resulted in promising therapeutic strategies. Expounding the heterogeneity for ovarian cancer (OC) with the cognition in developmental biology might be helpful to search for robust prognostic markers and effective treatments. In the present study, we employed single-cell RNA-seq with ovarian cancers, normal ovary, and embryo tissue to explore their heterogeneity. Then the differentiation process of clusters was explored; the pivotal cluster and markers were identified. Furthermore, the consensus clustering algorithm was used to explore the different clinical phenotypes in OC. At last, a prognostic model was construct and used to assess the prognosis for OCs. As a result, eight diverse clusters were identified, and the similarity existed in some clusters between embryo and tumours based on their gene expression. Meaningfully, a subtype of malignant epithelial cluster, PEG10+ EME, was associated with poor survival and was an intermediate stage of embryo to tumour. PEG10 was a CSC marker and might influence CSC self-renewal and promote cisplatin resistance via NOTCH pathway. Utilising specific gene profiles of PEG10+ EME based on public data sets, four phenotypes with different survival and clinical response to anti-PD-1/PD-L1 immunotherapy were identified. These insights allowed for the investigation of single-cell transcriptome of OCs and embryo, which advanced our current understanding of OC pathogenesis and resulted in promising therapeutic strategies.Expounding the heterogeneity for ovarian cancer (OC) with the cognition in developmental biology might be helpful to search for robust prognostic markers and effective treatments. In the present study, we employed single-cell RNA-seq with ovarian cancers, normal ovary, and embryo tissue to explore their heterogeneity. Then the differentiation process of clusters was explored; the pivotal cluster and markers were identified. Furthermore, the consensus clustering algorithm was used to explore the different clinical phenotypes in OC. At last, a prognostic model was construct and used to assess the prognosis for OCs. As a result, eight diverse clusters were identified, and the similarity existed in some clusters between embryo and tumours based on their gene expression. Meaningfully, a subtype of malignant epithelial cluster, PEG10+ EME, was associated with poor survival and was an intermediate stage of embryo to tumour. PEG10 was a CSC marker and might influence CSC self-renewal and promote cisplatin resistance via NOTCH pathway. Utilising specific gene profiles of PEG10+ EME based on public data sets, four phenotypes with different survival and clinical response to anti-PD-1/PD-L1 immunotherapy were identified. These insights allowed for the investigation of single-cell transcriptome of OCs and embryo, which advanced our current understanding of OC pathogenesis and resulted in promising therapeutic strategies. |
ArticleNumber | 1082 |
Author | Miao, Jinwei Yin, Chenghong Li, Jie Zhao, Hongyu Gao, Yan Yue, Wentao Chen, Suwen Li, Zhefeng |
Author_xml | – sequence: 1 givenname: Hongyu orcidid: 0000-0002-8999-3285 surname: Zhao fullname: Zhao, Hongyu organization: Central Laboratory, Beijing Obstetrics and Gynecology Hospital, Capital Medical University – sequence: 2 givenname: Yan orcidid: 0000-0003-2067-8241 surname: Gao fullname: Gao, Yan organization: Central Laboratory, Beijing Obstetrics and Gynecology Hospital, Capital Medical University – sequence: 3 givenname: Jinwei surname: Miao fullname: Miao, Jinwei organization: Department of Gynecologic Oncology, Beijing Obstetrics and Gynecology Hospital, Capital Medical University – sequence: 4 givenname: Suwen surname: Chen fullname: Chen, Suwen organization: Department of Family Planning, Beijing Obstetrics and Gynecology Hospital, Capital Medical University – sequence: 5 givenname: Jie surname: Li fullname: Li, Jie organization: Central Laboratory, Beijing Obstetrics and Gynecology Hospital, Capital Medical University – sequence: 6 givenname: Zhefeng surname: Li fullname: Li, Zhefeng organization: Central Laboratory, Beijing Obstetrics and Gynecology Hospital, Capital Medical University – sequence: 7 givenname: Chenghong orcidid: 0000-0002-2503-3285 surname: Yin fullname: Yin, Chenghong email: yinchh@ccmu.edu.cn organization: Central Laboratory, Beijing Obstetrics and Gynecology Hospital, Capital Medical University – sequence: 8 givenname: Wentao orcidid: 0000-0002-5917-1125 surname: Yue fullname: Yue, Wentao email: yuewt@ccmu.edu.cn organization: Central Laboratory, Beijing Obstetrics and Gynecology Hospital, Capital Medical University |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/34775482$$D View this record in MEDLINE/PubMed |
BookMark | eNp9Uk1r3DAUNCWl-Wj-QA_F0Esvbp8-bEuXQghtGggttOlZyNKzV4tX2kh2IP--2nWaJjlEICSeZkbzpDkuDnzwWBTvCHwiwMTnxAknsgJKKuCsFhV_VRxR4KTiQsiDR_vD4jSlNeTBGNC6eVMcMt62NRf0qLj-7fwwYmVwHMtfP86qhDflyg2rMc8plbpMWzSud6Y0OhrnA266eBf8rjDOacJYOl-GWx2d9hnjDca3xetejwlP79eT4s-3r9fn36urnxeX52dXlak5TBVFgthSQNtrNNCBEYTQBgQQIrQESUyjTd8QTRmIWpJWc0vAmNyF7TvBTorLRdcGvVbb6DY63qmgndoXQhyUjpMzI6pWtpJ3VtsaNees66y1nWxo07SsqQXLWl8Wre3cbdAa9FPU4xPRpyferdQQblU2Bo2ss8DHe4EYbmZMk9q4tHtW7THMSdFatgKgpiRDPzyDrsMcfX6qPQoIbbnMqPePHT1Y-fd5GUAXgIkhpYj9A4SA2oVELSFROSRqHxLFM0k8Ixk36cmFXVdufJnKFmrK9_gB43_bL7D-Aif3z-w |
CitedBy_id | crossref_primary_10_3390_ijms252413706 crossref_primary_10_3390_ijms23010216 crossref_primary_10_3390_ijms241310683 crossref_primary_10_1186_s12967_023_04094_7 crossref_primary_10_1016_j_psj_2025_104966 crossref_primary_10_1186_s12958_023_01116_3 crossref_primary_10_1016_j_pbiomolbio_2025_01_002 crossref_primary_10_3390_jcm12041279 crossref_primary_10_1039_D2MO00220E crossref_primary_10_3389_fimmu_2023_1288027 crossref_primary_10_1038_s41598_022_17645_7 crossref_primary_10_1186_s13048_024_01419_y crossref_primary_10_3389_fendo_2023_1168245 crossref_primary_10_1016_j_jpha_2023_08_014 |
Cites_doi | 10.1038/s41591-019-0750-6 10.1038/s41586-019-1158-7 10.1016/j.immuni.2013.10.003 10.1038/s41586-018-0698-6 10.1111/jcmm.13878 10.1371/journal.pone.0214110 10.1186/s13059-017-1382-0 10.1038/s41467-018-05805-1 10.1186/1471-2105-14-7 10.1001/jamaoncol.2015.5495 10.7150/thno.49345 10.1016/j.ccell.2020.01.003 10.1158/2159-8290.CD-18-0715 10.1038/nrclinonc.2010.196 10.1038/s41419-020-02840-z 10.1038/nbt.4096 10.3322/caac.21551 10.1158/1535-7163.MCT-19-1031 10.1016/j.ccell.2018.08.001 10.1016/j.immuni.2019.09.008 10.1038/nrg2556 10.1016/j.semcancer.2018.06.006 10.1038/s41577-019-0264-y 10.1200/JCO.2017.73.4293 10.1038/s41422-019-0195-y 10.1093/jnci/djz080 10.1158/0008-5472.CAN-19-2181 10.1016/j.cell.2014.12.033 10.1200/JCO.2016.69.9330 10.1038/s41586-019-1195-2 10.1016/j.cell.2011.02.013 10.1089/omi.2011.0118 10.1038/s41586-018-0670-5 10.1038/nrc3261 10.1038/nature23891 10.1016/j.ctrv.2016.07.001 10.1038/nbt.2859 10.1158/2159-8290.CD-19-0138 10.1371/journal.pone.0206785 10.1186/1471-2105-9-559 10.1002/cpbi.96 10.1093/nar/gkv1507 10.1016/j.celrep.2018.10.045 10.1038/s41591-018-0096-5 10.1093/bioinformatics/bts635 10.1038/s41591-020-0900-x 10.1016/j.immuni.2013.07.008 10.1093/bioinformatics/bts034 10.1038/s41591-019-0590-4 10.1186/1471-2164-11-S5-S1 10.1038/s41467-018-03282-0 10.1038/nprot.2008.211 10.1038/s41568-019-0178-9 |
ContentType | Journal Article |
Copyright | The Author(s) 2021 2021. The Author(s). The Author(s) 2021. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. |
Copyright_xml | – notice: The Author(s) 2021 – notice: 2021. The Author(s). – notice: The Author(s) 2021. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. |
DBID | C6C AAYXX CITATION CGR CUY CVF ECM EIF NPM 3V. 7X7 7XB 88A 88I 8FE 8FH 8FI 8FJ 8FK ABUWG AFKRA AZQEC BBNVY BENPR BHPHI CCPQU DWQXO FYUFA GHDGH GNUQQ HCIFZ K9. LK8 M0S M2P M7P PHGZM PHGZT PIMPY PKEHL PQEST PQGLB PQQKQ PQUKI PRINS Q9U 7X8 5PM DOA |
DOI | 10.1038/s41419-021-04358-4 |
DatabaseName | Springer Nature OA Free Journals CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed ProQuest Central (Corporate) Health & Medical Collection ProQuest Central (purchase pre-March 2016) Biology Database (Alumni Edition) Science Database (Alumni Edition) ProQuest SciTech Collection ProQuest Natural Science Collection Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central UK/Ireland ProQuest Central Essentials Biological Science Collection ProQuest Central Natural Science Collection ProQuest One Community College ProQuest Central Korea Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Central Student SciTech Premium Collection ProQuest Health & Medical Complete (Alumni) ProQuest Biological Science Collection ProQuest Health & Medical Collection Science Database Biological Science Database ProQuest Central Premium ProQuest One Academic (New) Publicly Available Content Database ProQuest One Academic Middle East (New) ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Applied & Life Sciences ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China ProQuest Central Basic MEDLINE - Academic PubMed Central (Full Participant titles) DOAJ Directory of Open Access Journals |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Publicly Available Content Database ProQuest Central Student ProQuest One Academic Middle East (New) ProQuest Central Essentials ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) SciTech Premium Collection ProQuest One Community College ProQuest Natural Science Collection ProQuest Central China ProQuest Biology Journals (Alumni Edition) ProQuest Central ProQuest One Applied & Life Sciences Health Research Premium Collection Health and Medicine Complete (Alumni Edition) Natural Science Collection ProQuest Central Korea Biological Science Collection ProQuest Central (New) ProQuest Science Journals (Alumni Edition) ProQuest Biological Science Collection ProQuest Central Basic ProQuest Science Journals ProQuest One Academic Eastern Edition ProQuest Hospital Collection Health Research Premium Collection (Alumni) Biological Science Database ProQuest SciTech Collection ProQuest Hospital Collection (Alumni) ProQuest Health & Medical Complete ProQuest One Academic UKI Edition ProQuest One Academic ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic |
DatabaseTitleList | MEDLINE Publicly Available Content Database MEDLINE - Academic CrossRef |
Database_xml | – sequence: 1 dbid: C6C name: Springer Nature OA Free Journals url: http://www.springeropen.com/ sourceTypes: Publisher – sequence: 2 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 3 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 4 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 5 dbid: BENPR name: ProQuest Central url: https://www.proquest.com/central sourceTypes: Aggregation Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Biology |
EISSN | 2041-4889 |
EndPage | 11 |
ExternalDocumentID | oai_doaj_org_article_79794bdad5ea443bbdddb96266736583 PMC8590695 34775482 10_1038_s41419_021_04358_4 |
Genre | Research Support, Non-U.S. Gov't Journal Article |
GrantInformation_xml | – fundername: Beijing Municipal Administration of Hospitals Clinical Medicine Development of Special Funding Support grantid: No. XMLX201705 funderid: https://doi.org/10.13039/501100009331 – fundername: National Natural Science Foundation of China (National Science Foundation of China) grantid: No. 81672838 funderid: https://doi.org/10.13039/501100001809 – fundername: ; grantid: No. 81672838 – fundername: ; grantid: No. XMLX201705 |
GroupedDBID | --- 0R~ 3V. 53G 5VS 70F 7X7 88A 88I 8FE 8FH 8FI 8FJ AAJSJ ABUWG ACGFS ACSMW ADBBV AENEX AFKRA AJTQC ALIPV ALMA_UNASSIGNED_HOLDINGS AOIJS AZQEC BAWUL BBNVY BCNDV BENPR BHPHI BPHCQ BVXVI C6C CCPQU DIK DWQXO E3Z EBLON EBS EMOBN FRP FYUFA GNUQQ GROUPED_DOAJ HCIFZ HMCUK HYE HZ~ KQ8 LK8 M0L M2P M48 M7P M~E NAO O5R O5S O9- OK1 PIMPY PQQKQ PROAC RNT RPM SNYQT TR2 UKHRP W2D AASML AAYXX CITATION PHGZM PHGZT CGR CUY CVF ECM EIF NPM 7XB 8FK AARCD K9. PKEHL PQEST PQGLB PQUKI PRINS Q9U 7X8 5PM PUEGO |
ID | FETCH-LOGICAL-c540t-2e1ee720edfaec0b0c81126080118a9091c6acf61a23085917a4d10cc025dfb83 |
IEDL.DBID | M48 |
ISSN | 2041-4889 |
IngestDate | Wed Aug 27 01:32:12 EDT 2025 Thu Aug 21 14:07:24 EDT 2025 Fri Jul 11 00:35:29 EDT 2025 Wed Aug 13 07:40:41 EDT 2025 Thu Jan 02 22:52:25 EST 2025 Tue Jul 01 03:49:58 EDT 2025 Thu Apr 24 22:58:05 EDT 2025 Fri Feb 21 02:37:18 EST 2025 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 11 |
Language | English |
License | 2021. The Author(s). Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c540t-2e1ee720edfaec0b0c81126080118a9091c6acf61a23085917a4d10cc025dfb83 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
ORCID | 0000-0002-5917-1125 0000-0002-2503-3285 0000-0002-8999-3285 0000-0003-2067-8241 |
OpenAccessLink | http://journals.scholarsportal.info/openUrl.xqy?doi=10.1038/s41419-021-04358-4 |
PMID | 34775482 |
PQID | 2597012749 |
PQPubID | 2041963 |
PageCount | 11 |
ParticipantIDs | doaj_primary_oai_doaj_org_article_79794bdad5ea443bbdddb96266736583 pubmedcentral_primary_oai_pubmedcentral_nih_gov_8590695 proquest_miscellaneous_2597800521 proquest_journals_2597012749 pubmed_primary_34775482 crossref_primary_10_1038_s41419_021_04358_4 crossref_citationtrail_10_1038_s41419_021_04358_4 springer_journals_10_1038_s41419_021_04358_4 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2021-11-13 |
PublicationDateYYYYMMDD | 2021-11-13 |
PublicationDate_xml | – month: 11 year: 2021 text: 2021-11-13 day: 13 |
PublicationDecade | 2020 |
PublicationPlace | London |
PublicationPlace_xml | – name: London – name: England |
PublicationTitle | Cell death & disease |
PublicationTitleAbbrev | Cell Death Dis |
PublicationTitleAlternate | Cell Death Dis |
PublicationYear | 2021 |
Publisher | Nature Publishing Group UK Springer Nature B.V Nature Publishing Group |
Publisher_xml | – name: Nature Publishing Group UK – name: Springer Nature B.V – name: Nature Publishing Group |
References | Urzua, Owens, Zhang, Cherry, Sharp, Munroe (CR32) 2010; 11 Crow, Paul, Ballouz, Huang, Gillis (CR49) 2018; 9 Kawai, Imada, Akamatsu, Zhang, Seiler, Hayashi (CR30) 2020; 19 Dravis, Chung, Lytle, Herrera-Valdez, Luna, Trejo (CR25) 2018; 34 Zhang, Wan, Zhang, Jiang, Gu, Ma (CR34) 2021; 11 Shapovalova, Lee, Li, Vander Griend, Coleman, Nelson (CR29) 2019; 79 Vladoiu, El-Hamamy, Donovan, Farooq, Holgado, Sundaravadanam (CR23) 2019; 572 Puram, Tirosh, Parikh, Patel, Yizhak, Gillespie (CR12) 2017; 171 Norquist, Harrell, Brady, Walsh, Lee, Gulsuner (CR6) 2016; 2 Wolf, Angerer, Theis (CR48) 2018; 19 Marusyk, Almendro, Polyak (CR9) 2012; 12 Vos, Fakkert, de Hullu, van Altena, Sie, Ouchene (CR3) 2020; 112 Brock, Chang, Huang (CR10) 2009; 10 Li, Guo, Lu, Mohiuddin Chowdhury, Zhang, Ren (CR28) 2020; 11 Pignata, Scambia, Bologna, Signoriello, Vergote, Wagner (CR4) 2017; 35 Vento-Tormo, Efremova, Botting, Turco, Vento-Tormo, Meyer (CR16) 2018; 563 Takebe, Harris, Warren, Ivy (CR37) 2011; 8 Zeng, Liu, Gong, Bai, Hou, He (CR38) 2019; 51 AbdulJabbar, Raza, Rosenthal, Jamal-Hanjani, Veeriah, Akarca (CR40) 2020; 26 Liu, Tian, Cao, Zhang, Wen, Zhou (CR33) 2019; 23 Butler, Hoffman, Smibert, Papalexi, Satija (CR43) 2018; 36 Mathys, Davila-Velderrain, Peng, Gao, Mohammadi, Young (CR11) 2019; 570 CR47 Langfelder, Horvath (CR55) 2008; 9 Siegel, Miller, Jemal (CR1) 2019; 69 Dobin, Davis, Schlesinger, Drenkow, Zaleski, Jha (CR42) 2013; 29 Lin, Harrell, Oza, Oaknin, Ray-Coquard, Tinker (CR7) 2019; 9 Lambrechts, Wauters, Boeckx, Aibar, Nittner, Burton (CR18) 2018; 24 Kumar, Coronel, Somalanka, Raju, Aning, An (CR2) 2018; 9 Trapnell, Cacchiarelli, Grimsby, Pokharel, Li, Morse (CR44) 2014; 32 Hanahan, Weinberg (CR21) 2011; 144 He, Meghani, Caron, Yang, Ronato, Bian (CR8) 2018; 563 Carnero, Garcia-Mayea, Mir, Lorente, Rubio, ME (CR36) 2016; 49 Smith, Shi, Gu, Donaghey, Clement, Cacchiarelli (CR26) 2017; 549 Rooney, Shukla, Wu, Getz, Hacohen (CR31) 2015; 160 Daassi, Mahoney, Freeman (CR41) 2020; 20 Yu, Wang, Han, He (CR45) 2012; 16 Pierce (CR20) 1983; 113 Rosenthal, Fraser, Philpott, Manchanda, Burnell, Badman (CR5) 2017; 35 Colaprico, Silva, Olsen, Garofano, Cava, Garolini (CR52) 2016; 44 Hu, Artibani, Alsaadi, Wietek, Morotti, Shi (CR14) 2020; 37 Hanzelmann, Castelo, Guinney (CR46) 2013; 14 Fernandez, Rahman, Fernandez, Chudnovskiy, Amir, Amadori (CR17) 2019; 25 Shih, Menzin, Whyte, Lovecchio, Liew, Khalili (CR19) 2018; 13 CR22 Marquardt, Solanki, Spitschak, Vera, Putzer (CR35) 2018; 53 Abed, Verschueren, Budayeva, Liu, Kirkpatrick, Reja (CR27) 2019; 14 Yu (CR50) 2020; 69 Bindea, Mlecnik, Tosolini, Kirilovsky, Waldner, Obenauf (CR54) 2013; 39 Peng, Sun, Chen, Zhou, Chen, Chen (CR15) 2019; 29 Galon, Angell, Bedognetti, Marincola (CR39) 2013; 39 Suo, Zhu, Saadatpour, Fei, Guo, Yuan (CR51) 2018; 25 Laughney, Hu, Campbell, Bakhoum, Setty, Lavallee (CR24) 2020; 26 Halbritter, Farlik, Schwentner, Jug, Fortelny, Schnoller (CR13) 2019; 9 Leek, Johnson, Parker, Jaffe, Storey (CR53) 2012; 28 MS Rooney (4358_CR31) 2015; 160 D Hanahan (4358_CR21) 2011; 144 S Hanzelmann (4358_CR46) 2013; 14 F Halbritter (4358_CR13) 2019; 9 G Bindea (4358_CR54) 2013; 39 C Dravis (4358_CR25) 2018; 34 S Pignata (4358_CR4) 2017; 35 AM Laughney (4358_CR24) 2020; 26 JR Vos (4358_CR3) 2020; 112 FA Wolf (4358_CR48) 2018; 19 J Peng (4358_CR15) 2019; 29 SV Puram (4358_CR12) 2017; 171 N Takebe (4358_CR37) 2011; 8 C Trapnell (4358_CR44) 2014; 32 Z Hu (4358_CR14) 2020; 37 A Brock (4358_CR10) 2009; 10 P Langfelder (4358_CR55) 2008; 9 M Abed (4358_CR27) 2019; 14 Z Liu (4358_CR33) 2019; 23 RL Siegel (4358_CR1) 2019; 69 L Zhang (4358_CR34) 2021; 11 DM Fernandez (4358_CR17) 2019; 25 AN Rosenthal (4358_CR5) 2017; 35 JT Leek (4358_CR53) 2012; 28 G Yu (4358_CR50) 2020; 69 Y Zeng (4358_CR38) 2019; 51 4358_CR47 YJ He (4358_CR8) 2018; 563 GB Pierce (4358_CR20) 1983; 113 M Shapovalova (4358_CR29) 2019; 79 MC Vladoiu (4358_CR23) 2019; 572 D Daassi (4358_CR41) 2020; 20 AJ Shih (4358_CR19) 2018; 13 R Kumar (4358_CR2) 2018; 9 Y Kawai (4358_CR30) 2020; 19 K AbdulJabbar (4358_CR40) 2020; 26 G Yu (4358_CR45) 2012; 16 A Butler (4358_CR43) 2018; 36 H Mathys (4358_CR11) 2019; 570 M Crow (4358_CR49) 2018; 9 KK Lin (4358_CR7) 2019; 9 ZD Smith (4358_CR26) 2017; 549 A Colaprico (4358_CR52) 2016; 44 A Marusyk (4358_CR9) 2012; 12 BM Norquist (4358_CR6) 2016; 2 D Lambrechts (4358_CR18) 2018; 24 R Vento-Tormo (4358_CR16) 2018; 563 A Dobin (4358_CR42) 2013; 29 S Suo (4358_CR51) 2018; 25 J Galon (4358_CR39) 2013; 39 Y Li (4358_CR28) 2020; 11 A Carnero (4358_CR36) 2016; 49 4358_CR22 U Urzua (4358_CR32) 2010; 11 S Marquardt (4358_CR35) 2018; 53 |
References_xml | – ident: CR22 – volume: 26 start-page: 259 year: 2020 end-page: 69. ident: CR24 article-title: Regenerative lineages and immune-mediated pruning in lung cancer metastasis publication-title: Nat Med doi: 10.1038/s41591-019-0750-6 – volume: 572 start-page: 67 year: 2019 end-page: 73 ident: CR23 article-title: Childhood cerebellar tumours mirror conserved fetal transcriptional programs publication-title: Nature doi: 10.1038/s41586-019-1158-7 – volume: 39 start-page: 782 year: 2013 end-page: 95 ident: CR54 article-title: Spatiotemporal dynamics of intratumoral immune cells reveal the immune landscape in human cancer publication-title: Immunity. doi: 10.1016/j.immuni.2013.10.003 – volume: 563 start-page: 347 year: 2018 end-page: 53. ident: CR16 article-title: Single-cell reconstruction of the early maternal-fetal interface in humans publication-title: Nature. doi: 10.1038/s41586-018-0698-6 – volume: 23 start-page: 70 year: 2019 end-page: 82 ident: CR33 article-title: TSG101 promotes the proliferation, migration and invasion of hepatocellular carcinoma cells by regulating the PEG10 publication-title: J Cell Mol Med. doi: 10.1111/jcmm.13878 – volume: 14 start-page: e0214110 year: 2019 ident: CR27 article-title: The Gag protein PEG10 binds to RNA and regulates trophoblast stem cell lineage specification publication-title: PLoS ONE doi: 10.1371/journal.pone.0214110 – volume: 19 year: 2018 ident: CR48 article-title: SCANPY: large-scale single-cell gene expression data analysis publication-title: Genome Biol doi: 10.1186/s13059-017-1382-0 – volume: 9 year: 2018 ident: CR2 article-title: Mitochondrial uncoupling reveals a novel therapeutic opportunity for p53-defective cancers publication-title: Nat Commun doi: 10.1038/s41467-018-05805-1 – volume: 14 year: 2013 ident: CR46 article-title: GSVA: gene set variation analysis for microarray and RNA-seq data publication-title: BMC Bioinformatics doi: 10.1186/1471-2105-14-7 – volume: 2 start-page: 482 year: 2016 end-page: 90 ident: CR6 article-title: Inherited mutations in women with ovarian carcinoma publication-title: JAMA Oncol. doi: 10.1001/jamaoncol.2015.5495 – volume: 11 start-page: 1100 year: 2021 end-page: 14. ident: CR34 article-title: IGF2BP1 overexpression stabilizes PEG10 mRNA in an m6A-dependent manner and promotes endometrial cancer progression publication-title: Theranostics. doi: 10.7150/thno.49345 – volume: 37 start-page: 226.e7 year: 2020 end-page: 42.e7 ident: CR14 article-title: The repertoire of serous ovarian cancer non-genetic heterogeneity revealed by single-cell sequencing of normal fallopian tube epithelial cells publication-title: Cancer Cell doi: 10.1016/j.ccell.2020.01.003 – volume: 9 start-page: 210 year: 2019 end-page: 9 ident: CR7 article-title: BRCA reversion mutations in circulating tumor DNA predict primary and acquired resistance to the PARP inhibitor rucaparib in high-grade ovarian carcinoma publication-title: Cancer Discov doi: 10.1158/2159-8290.CD-18-0715 – volume: 8 start-page: 97 year: 2011 end-page: 106 ident: CR37 article-title: Targeting cancer stem cells by inhibiting Wnt, Notch, and Hedgehog pathways publication-title: Nat Rev Clin Oncol doi: 10.1038/nrclinonc.2010.196 – volume: 11 year: 2020 ident: CR28 article-title: LncRNA SNAI3-AS1 promotes PEG10-mediated proliferation and metastasis via decoying of miR-27a-3p and miR-34a-5p in hepatocellular carcinoma publication-title: Cell Death Dis doi: 10.1038/s41419-020-02840-z – volume: 36 start-page: 411 year: 2018 end-page: 20. ident: CR43 article-title: Integrating single-cell transcriptomic data across different conditions, technologies, and species publication-title: Nat Biotechnol doi: 10.1038/nbt.4096 – volume: 69 start-page: 7 year: 2019 end-page: 34 ident: CR1 article-title: Cancer statistics, 2019 publication-title: CA Cancer J Clin. doi: 10.3322/caac.21551 – volume: 19 start-page: 2210 year: 2020 end-page: 20. ident: CR30 article-title: Paternally expressed gene 10 (PEG10) promotes growth, invasion, and survival of bladder cancer publication-title: Mol Cancer Ther doi: 10.1158/1535-7163.MCT-19-1031 – volume: 34 start-page: 466.e6 year: 2018 end-page: 82.e6 ident: CR25 article-title: Epigenetic and transcriptomic profiling of mammary gland development and tumor models disclose regulators of cell state plasticity publication-title: Cancer Cell doi: 10.1016/j.ccell.2018.08.001 – volume: 51 start-page: 930.e6 year: 2019 end-page: 48.e6 ident: CR38 article-title: Single-cell RNA sequencing resolves spatiotemporal development of pre-thymic lymphoid progenitors and thymus organogenesis in human embryos publication-title: Immunity. doi: 10.1016/j.immuni.2019.09.008 – volume: 10 start-page: 336 year: 2009 end-page: 42 ident: CR10 article-title: Non-genetic heterogeneity-a mutation-independent driving force for the somatic evolution of tumours publication-title: Nat Rev Genet doi: 10.1038/nrg2556 – ident: CR47 – volume: 171 start-page: 1611 year: 2017 end-page: 24.e24 ident: CR12 article-title: Single-cell transcriptomic analysis of primary and metastatic tumor ecosystems in head and neck publication-title: Cancer Cell – volume: 53 start-page: 90 year: 2018 end-page: 109 ident: CR35 article-title: Emerging functional markers for cancer stem cell-based therapies: Understanding signaling networks for targeting metastasis publication-title: Semin Cancer Biol doi: 10.1016/j.semcancer.2018.06.006 – volume: 20 start-page: 209 year: 2020 end-page: 15. ident: CR41 article-title: The importance of exosomal PDL1 in tumour immune evasion publication-title: Nat Rev Immunol doi: 10.1038/s41577-019-0264-y – volume: 35 start-page: 3347 year: 2017 end-page: 53 ident: CR4 article-title: Randomized controlled trial testing the efficacy of platinum-free interval prolongation in advanced ovarian cancer: the MITO-8, MaNGO, BGOG-Ov1, AGO-Ovar2.16, ENGOT-Ov1, GCIG Study publication-title: J Clin Oncol. doi: 10.1200/JCO.2017.73.4293 – volume: 29 start-page: 725 year: 2019 end-page: 38. ident: CR15 article-title: Single-cell RNA-seq highlights intra-tumoral heterogeneity and malignant progression in pancreatic ductal adenocarcinoma publication-title: Cell Res doi: 10.1038/s41422-019-0195-y – volume: 112 start-page: 161 year: 2020 end-page: 9 ident: CR3 article-title: Universal tumor DNA BRCA1/2 testing of ovarian cancer: prescreening PARPi treatment and genetic predisposition publication-title: J Natl Cancer Inst. doi: 10.1093/jnci/djz080 – volume: 79 start-page: 5668 year: 2019 end-page: 80. ident: CR29 article-title: PEG10 promoter-driven expression of reporter genes enables molecular imaging of lethal prostate cancer publication-title: Cancer Res doi: 10.1158/0008-5472.CAN-19-2181 – volume: 160 start-page: 48 year: 2015 end-page: 61 ident: CR31 article-title: Molecular and genetic properties of tumors associated with local immune cytolytic activity publication-title: Cell. doi: 10.1016/j.cell.2014.12.033 – volume: 113 start-page: 117 year: 1983 end-page: 24 ident: CR20 article-title: The cancer cell and its control by the embryo. Rous-Whipple Award lecture publication-title: Am J Pathol. – volume: 35 start-page: 1411 year: 2017 end-page: 20. ident: CR5 article-title: Evidence of stage shift in women diagnosed with ovarian cancer during phase II of the United Kingdom Familial Ovarian Cancer Screening Study publication-title: J Clin Oncol. doi: 10.1200/JCO.2016.69.9330 – volume: 570 start-page: 332 year: 2019 end-page: 7 ident: CR11 article-title: Single-cell transcriptomic analysis of Alzheimer’s disease publication-title: Nature. doi: 10.1038/s41586-019-1195-2 – volume: 144 start-page: 646 year: 2011 end-page: 74 ident: CR21 article-title: Hallmarks of cancer: the next generation publication-title: Cell. doi: 10.1016/j.cell.2011.02.013 – volume: 16 start-page: 284 year: 2012 end-page: 7 ident: CR45 article-title: clusterProfiler: an R package for comparing biological themes among gene clusters publication-title: OMICS. doi: 10.1089/omi.2011.0118 – volume: 563 start-page: 522 year: 2018 end-page: 6 ident: CR8 article-title: DYNLL1 binds to MRE11 to limit DNA end resection in BRCA1-deficient cells publication-title: Nature. doi: 10.1038/s41586-018-0670-5 – volume: 12 start-page: 323 year: 2012 end-page: 34 ident: CR9 article-title: Intra-tumour heterogeneity: a looking glass for cancer? publication-title: Nat Rev Cancer doi: 10.1038/nrc3261 – volume: 549 start-page: 543 year: 2017 end-page: 7 ident: CR26 article-title: Epigenetic restriction of extraembryonic lineages mirrors the somatic transition to cancer publication-title: Nature. doi: 10.1038/nature23891 – volume: 49 start-page: 25 year: 2016 end-page: 36 ident: CR36 article-title: The cancer stem-cell signaling network and resistance to therapy publication-title: Cancer Treat Rev doi: 10.1016/j.ctrv.2016.07.001 – volume: 32 start-page: 381 year: 2014 end-page: 6 ident: CR44 article-title: The dynamics and regulators of cell fate decisions are revealed by pseudotemporal ordering of single cells publication-title: Nat Biotechnol doi: 10.1038/nbt.2859 – volume: 9 start-page: 1406 year: 2019 end-page: 21. ident: CR13 article-title: Epigenomics and single-cell sequencing define a developmental hierarchy in langerhans cell histiocytosis publication-title: Cancer Discov doi: 10.1158/2159-8290.CD-19-0138 – volume: 13 start-page: e0206785 year: 2018 ident: CR19 article-title: Identification of grade and origin specific cell populations in serous epithelial ovarian cancer by single cell RNA-seq publication-title: PLoS ONE doi: 10.1371/journal.pone.0206785 – volume: 9 year: 2008 ident: CR55 article-title: WGCNA: an R package for weighted correlation network analysis publication-title: BMC Bioinformatics doi: 10.1186/1471-2105-9-559 – volume: 69 start-page: e96 year: 2020 ident: CR50 article-title: Using ggtree to visualize data on tree-like structures publication-title: Curr Protoc Bioinformatics doi: 10.1002/cpbi.96 – volume: 44 start-page: e71 year: 2016 ident: CR52 article-title: TCGAbiolinks: an R/Bioconductor package for integrative analysis of TCGA data publication-title: Nucleic Acids Res doi: 10.1093/nar/gkv1507 – volume: 25 start-page: 1436.e3 year: 2018 end-page: 45.e3 ident: CR51 article-title: Revealing the critical regulators of cell identity in the mouse cell atlas publication-title: Cell Rep doi: 10.1016/j.celrep.2018.10.045 – volume: 24 start-page: 1277 year: 2018 end-page: 89. ident: CR18 article-title: Phenotype molding of stromal cells in the lung tumor microenvironment publication-title: Nat Med doi: 10.1038/s41591-018-0096-5 – volume: 29 start-page: 15 year: 2013 end-page: 21 ident: CR42 article-title: STAR: ultrafast universal RNA-seq aligner publication-title: Bioinformatics. doi: 10.1093/bioinformatics/bts635 – volume: 26 start-page: 1054 year: 2020 end-page: 62. ident: CR40 article-title: Geospatial immune variability illuminates differential evolution of lung adenocarcinoma publication-title: Nat Med doi: 10.1038/s41591-020-0900-x – volume: 39 start-page: 11 year: 2013 end-page: 26 ident: CR39 article-title: The continuum of cancer immunosurveillance: prognostic, predictive, and mechanistic signatures publication-title: Immunity. doi: 10.1016/j.immuni.2013.07.008 – volume: 28 start-page: 882 year: 2012 end-page: 3 ident: CR53 article-title: The sva package for removing batch effects and other unwanted variation in high-throughput experiments publication-title: Bioinformatics. doi: 10.1093/bioinformatics/bts034 – volume: 25 start-page: 1576 year: 2019 end-page: 88. ident: CR17 article-title: Single-cell immune landscape of human atherosclerotic plaques publication-title: Nat Med doi: 10.1038/s41591-019-0590-4 – volume: 11 year: 2010 ident: CR32 article-title: Tumor and reproductive traits are linked by RNA metabolism genes in the mouse ovary: a transcriptome-phenotype association analysis publication-title: BMC Genomics doi: 10.1186/1471-2164-11-S5-S1 – volume: 9 year: 2018 ident: CR49 article-title: Characterizing the replicability of cell types defined by single cell RNA-sequencing data using MetaNeighbor publication-title: Nat Commun doi: 10.1038/s41467-018-03282-0 – volume: 53 start-page: 90 year: 2018 ident: 4358_CR35 publication-title: Semin Cancer Biol doi: 10.1016/j.semcancer.2018.06.006 – volume: 36 start-page: 411 year: 2018 ident: 4358_CR43 publication-title: Nat Biotechnol doi: 10.1038/nbt.4096 – volume: 79 start-page: 5668 year: 2019 ident: 4358_CR29 publication-title: Cancer Res doi: 10.1158/0008-5472.CAN-19-2181 – volume: 44 start-page: e71 year: 2016 ident: 4358_CR52 publication-title: Nucleic Acids Res doi: 10.1093/nar/gkv1507 – volume: 14 start-page: e0214110 year: 2019 ident: 4358_CR27 publication-title: PLoS ONE doi: 10.1371/journal.pone.0214110 – volume: 11 year: 2020 ident: 4358_CR28 publication-title: Cell Death Dis doi: 10.1038/s41419-020-02840-z – volume: 572 start-page: 67 year: 2019 ident: 4358_CR23 publication-title: Nature doi: 10.1038/s41586-019-1158-7 – volume: 144 start-page: 646 year: 2011 ident: 4358_CR21 publication-title: Cell. doi: 10.1016/j.cell.2011.02.013 – volume: 69 start-page: e96 year: 2020 ident: 4358_CR50 publication-title: Curr Protoc Bioinformatics doi: 10.1002/cpbi.96 – volume: 171 start-page: 1611 year: 2017 ident: 4358_CR12 publication-title: Cancer Cell – volume: 28 start-page: 882 year: 2012 ident: 4358_CR53 publication-title: Bioinformatics. doi: 10.1093/bioinformatics/bts034 – volume: 25 start-page: 1576 year: 2019 ident: 4358_CR17 publication-title: Nat Med doi: 10.1038/s41591-019-0590-4 – volume: 9 start-page: 210 year: 2019 ident: 4358_CR7 publication-title: Cancer Discov doi: 10.1158/2159-8290.CD-18-0715 – volume: 34 start-page: 466.e6 year: 2018 ident: 4358_CR25 publication-title: Cancer Cell doi: 10.1016/j.ccell.2018.08.001 – volume: 29 start-page: 15 year: 2013 ident: 4358_CR42 publication-title: Bioinformatics. doi: 10.1093/bioinformatics/bts635 – volume: 49 start-page: 25 year: 2016 ident: 4358_CR36 publication-title: Cancer Treat Rev doi: 10.1016/j.ctrv.2016.07.001 – volume: 14 year: 2013 ident: 4358_CR46 publication-title: BMC Bioinformatics doi: 10.1186/1471-2105-14-7 – volume: 563 start-page: 522 year: 2018 ident: 4358_CR8 publication-title: Nature. doi: 10.1038/s41586-018-0670-5 – volume: 35 start-page: 1411 year: 2017 ident: 4358_CR5 publication-title: J Clin Oncol. doi: 10.1200/JCO.2016.69.9330 – volume: 24 start-page: 1277 year: 2018 ident: 4358_CR18 publication-title: Nat Med doi: 10.1038/s41591-018-0096-5 – volume: 19 year: 2018 ident: 4358_CR48 publication-title: Genome Biol doi: 10.1186/s13059-017-1382-0 – volume: 35 start-page: 3347 year: 2017 ident: 4358_CR4 publication-title: J Clin Oncol. doi: 10.1200/JCO.2017.73.4293 – volume: 51 start-page: 930.e6 year: 2019 ident: 4358_CR38 publication-title: Immunity. doi: 10.1016/j.immuni.2019.09.008 – volume: 26 start-page: 1054 year: 2020 ident: 4358_CR40 publication-title: Nat Med doi: 10.1038/s41591-020-0900-x – volume: 32 start-page: 381 year: 2014 ident: 4358_CR44 publication-title: Nat Biotechnol doi: 10.1038/nbt.2859 – volume: 9 year: 2018 ident: 4358_CR2 publication-title: Nat Commun doi: 10.1038/s41467-018-05805-1 – volume: 9 year: 2008 ident: 4358_CR55 publication-title: BMC Bioinformatics doi: 10.1186/1471-2105-9-559 – volume: 69 start-page: 7 year: 2019 ident: 4358_CR1 publication-title: CA Cancer J Clin. doi: 10.3322/caac.21551 – volume: 23 start-page: 70 year: 2019 ident: 4358_CR33 publication-title: J Cell Mol Med. doi: 10.1111/jcmm.13878 – volume: 25 start-page: 1436.e3 year: 2018 ident: 4358_CR51 publication-title: Cell Rep doi: 10.1016/j.celrep.2018.10.045 – volume: 29 start-page: 725 year: 2019 ident: 4358_CR15 publication-title: Cell Res doi: 10.1038/s41422-019-0195-y – volume: 113 start-page: 117 year: 1983 ident: 4358_CR20 publication-title: Am J Pathol. – volume: 12 start-page: 323 year: 2012 ident: 4358_CR9 publication-title: Nat Rev Cancer doi: 10.1038/nrc3261 – volume: 8 start-page: 97 year: 2011 ident: 4358_CR37 publication-title: Nat Rev Clin Oncol doi: 10.1038/nrclinonc.2010.196 – volume: 112 start-page: 161 year: 2020 ident: 4358_CR3 publication-title: J Natl Cancer Inst. doi: 10.1093/jnci/djz080 – volume: 11 start-page: 1100 year: 2021 ident: 4358_CR34 publication-title: Theranostics. doi: 10.7150/thno.49345 – volume: 160 start-page: 48 year: 2015 ident: 4358_CR31 publication-title: Cell. doi: 10.1016/j.cell.2014.12.033 – volume: 9 start-page: 1406 year: 2019 ident: 4358_CR13 publication-title: Cancer Discov doi: 10.1158/2159-8290.CD-19-0138 – volume: 19 start-page: 2210 year: 2020 ident: 4358_CR30 publication-title: Mol Cancer Ther doi: 10.1158/1535-7163.MCT-19-1031 – ident: 4358_CR47 doi: 10.1038/nprot.2008.211 – volume: 39 start-page: 11 year: 2013 ident: 4358_CR39 publication-title: Immunity. doi: 10.1016/j.immuni.2013.07.008 – volume: 39 start-page: 782 year: 2013 ident: 4358_CR54 publication-title: Immunity. doi: 10.1016/j.immuni.2013.10.003 – volume: 10 start-page: 336 year: 2009 ident: 4358_CR10 publication-title: Nat Rev Genet doi: 10.1038/nrg2556 – volume: 26 start-page: 259 year: 2020 ident: 4358_CR24 publication-title: Nat Med doi: 10.1038/s41591-019-0750-6 – volume: 563 start-page: 347 year: 2018 ident: 4358_CR16 publication-title: Nature. doi: 10.1038/s41586-018-0698-6 – volume: 37 start-page: 226.e7 year: 2020 ident: 4358_CR14 publication-title: Cancer Cell doi: 10.1016/j.ccell.2020.01.003 – volume: 549 start-page: 543 year: 2017 ident: 4358_CR26 publication-title: Nature. doi: 10.1038/nature23891 – volume: 20 start-page: 209 year: 2020 ident: 4358_CR41 publication-title: Nat Rev Immunol doi: 10.1038/s41577-019-0264-y – volume: 2 start-page: 482 year: 2016 ident: 4358_CR6 publication-title: JAMA Oncol. doi: 10.1001/jamaoncol.2015.5495 – volume: 570 start-page: 332 year: 2019 ident: 4358_CR11 publication-title: Nature. doi: 10.1038/s41586-019-1195-2 – ident: 4358_CR22 doi: 10.1038/s41568-019-0178-9 – volume: 11 year: 2010 ident: 4358_CR32 publication-title: BMC Genomics doi: 10.1186/1471-2164-11-S5-S1 – volume: 16 start-page: 284 year: 2012 ident: 4358_CR45 publication-title: OMICS. doi: 10.1089/omi.2011.0118 – volume: 9 year: 2018 ident: 4358_CR49 publication-title: Nat Commun doi: 10.1038/s41467-018-03282-0 – volume: 13 start-page: e0206785 year: 2018 ident: 4358_CR19 publication-title: PLoS ONE doi: 10.1371/journal.pone.0206785 |
SSID | ssj0000330256 |
Score | 2.3951533 |
Snippet | Expounding the heterogeneity for ovarian cancer (OC) with the cognition in developmental biology might be helpful to search for robust prognostic markers and... Abstract Expounding the heterogeneity for ovarian cancer (OC) with the cognition in developmental biology might be helpful to search for robust prognostic... |
SourceID | doaj pubmedcentral proquest pubmed crossref springer |
SourceType | Open Website Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 1082 |
SubjectTerms | 13/1 13/2 13/31 13/89 13/95 38/47 38/77 38/91 45/41 631/67/580 631/67/69 Antibodies Biochemistry Biomarkers, Tumor - metabolism Biomedical and Life Sciences Carcinoma, Ovarian Epithelial - genetics Cell Biology Cell Culture Cell self-renewal Cisplatin Cognition Developmental biology Female Gene expression Humans Immunology Immunotherapy Incidence Life Sciences Medical prognosis Ovarian cancer PD-1 protein PD-L1 protein Phenotypes Prognosis RNA-Seq - methods Single-Cell Analysis - methods Transcriptomes Treatment Outcome Tumors |
SummonAdditionalLinks | – databaseName: DOAJ Directory of Open Access Journals dbid: DOA link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1baxUxEB6kIPgi3l2tEsE3Dd3NdfexiqUI9kFb6FvIbbFw3FPPRei_dya759jj9cXXTQLhy2QzXzLzDcDLHlmDCbXlyvRIUGwjuG904krLILTsQ0iUnPzhxByfqffn-vxaqS-KCRvlgUfgDmyHFhOSTzp7pSSOTSl06IZTQJJui84nnnnXyFT5ByNNx8N8ypKpZXuwVI2ifB2B7BldhJarnZOoCPb_zsv8NVjypxfTchAd3YHbkwfJDseZ34UbebgHN8eaklf34fQTjpplTjfy7OPJIV_mr4xEiWdEw5fMM0qupAAhFqmO0DDPX8LiihRyWZytSTeBXQxs_g1JtB-wD1rF4gGcHb07fXvMp9IJPKILtuIiNzlbUefU-xzrUMeWcoXQPURC4TsELBofe9N4pCAkYWe9Sk0dI6KW-tDKh7A3zIf8GJjvYrBtLXsRKA3VdFEnE4VJ2lhcgFhBs4HRxUlXnMpbzFx535atG6F3CL0r0DtVwavtmMtRVeOvvd_Q6mx7kiJ2-YB24iY7cf-ykwr2N2vrpm26dMj9LL29q66CF9tm3GC0Rn7I8_XYp6Xb86aCR6MpbGciFQkItqICu2MkO1PdbRkuPhcRbwS9Np2u4PXGnH5M689QPPkfUDyFW4L2AQUzyn3YWy3W-Rm6VqvwvOyi7xbwHUg priority: 102 providerName: Directory of Open Access Journals – databaseName: Health & Medical Collection dbid: 7X7 link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1La9wwEB7alEIvJenTTVJU6K0VsS1Zsk8hLQ2h0BzaBPYm9HIb2NjJereQf58Z2-uwfeRqSSCPRtI3o5lvAN7XaDUol2ouVY0Gis5ybrMicFkIlxeidi5QcvK3U3VyLr_OitnocOvGsMr1mdgf1KH15CM_QJiu6ZlUVodX15yqRtHr6lhC4yE8IuoyCunSMz35WFI01vFKH3NlUlEedDKTlLWTow2NQKHkcuM-6mn7_4U1_w6Z_OPdtL-Ojrfh6Ygj2dGw8DvwIDbP4PFQWfLmOZz9wFHzyMkvz76fHvEuXjOiJp6TMd4xyyjFksKEmKdqQk0bL93ihnhymZ-viD2BXTSs_Y2mtG2wD-rG4gWcH385-3zCxwIK3CMQW_I8ZjHqPI2httGnLvUlZQwhSESzwlYIFbyyvlaZRUOEiOy0lSFLvUephdqV4iVsNW0TXwOzlXe6TEWdO0pGVZUvgvK5CoXSCGJ8AtlajMaP7OJU5GJu-lduUZpB9AZFb3rRG5nAh2nM1cCtcW_vT7Q6U0_ixe4_tIufZtxmRld4vrhgQxGtlAI1LQRXodFG4WtFKRLYW6-tGTdrZ-5UK4F3UzNuM1oj28R2NfQpyYeeJfBqUIVpJkISjWCZJ6A3lGRjqpstzcWvnsobhZ6qqkjg41qd7qb1f1G8uf8vduFJThpOwYpiD7aWi1XcR-i0dG_7_XEL4d4Ulw priority: 102 providerName: ProQuest – databaseName: Springer Nature OA Free Journals dbid: C6C link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1baxUxEB5qRfBFvLtaJYJvuribZJPdx3qwFME-aAt9C7mtFk539VyE_ntnshc5WgVfdycwTCaZ-ZKZLwCvWkQNyhU6l6pFgKJLntuyCrmshOOVaJ0L1Jz88UQdn8kP59X5HvCpFyYV7SdKy7RNT9Vhb9eylNRuwxH8YoSvc3kDbhJ1O3n1Qi3mc5UCATqG8bE_phD1NUN3YlCi6r8uv_yzTPK3u9IUgo7uwp0xd2SHg7b3YC929-HW8Jrk1QM4_YyjljGns3j26eQwX8fvjOiIlwTA18wyaquk0iDm6QWhro-XbnVF3LjML7fEmMAuOtb_QPhsO5RBf1g9hLOj96eL43x8NCH3mHxtch7LGDUvYmht9IUrfE1dQpgYIpSwDaYHXlnfqtIi-CDyOm1lKAvv0WqhdbV4BPtd38UnwGzjna4L0XJHDaiq8VVQnqtQKY2Ji8-gnMxo_MgoTg9bLE262Ra1GUxv0PQmmd7IDF7PY74NfBr_lH5HszNLEhd2-tCvvpjRN4xucE9xwYYqWikFelcIrkGgRiVrVS0yOJjm1owLdG0Q9Wm6dZdNBi_n37i0aI5sF_vtIFPTuXmZwePBFWZNhCTqwJpnoHecZEfV3T_dxddE341GL1RTZfBmcqdfav3dFE__T_wZ3Obk8VSwKA5gf7PaxueYPm3ci7RefgL3JBJL priority: 102 providerName: Springer Nature |
Title | Single-cell RNA-seq highlights a specific carcinoembryonic cluster in ovarian cancer |
URI | https://link.springer.com/article/10.1038/s41419-021-04358-4 https://www.ncbi.nlm.nih.gov/pubmed/34775482 https://www.proquest.com/docview/2597012749 https://www.proquest.com/docview/2597800521 https://pubmed.ncbi.nlm.nih.gov/PMC8590695 https://doaj.org/article/79794bdad5ea443bbdddb96266736583 |
Volume | 12 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9NAEB71IVAviDeGEhmJGxj8WO_aB4TSKFUVqRFqGyk3a18ulYxNnQSRC7-dGT-CAoEDF1uyd-XVPLzz7e58A_A6R9TAlS88xnMEKCIIPRnExmNxpMI4ypUylJx8PuVnMzaZx_M96MsddQJc7IR2VE9qVhfvvt-uP6LDf2hTxpP3CxYwSsUJERjj7J94bB8OcWYS5KjnXbjf_JkRvOMU3-XO7O56BHcjRrRwSbg1VTWM_rvC0D9PU_62pdrMVKf34V4XYrrD1iYewJ4tH8Kdtujk-hFcXWKvwnq0ZO9eTIfewt66xFpcEE5fuNKl7Es6QeRqKjRUVvaLqtdEoevqYkXECu5N6VbfEGXLEtug2dSPYXY6vhqdeV1tBU9jjLb0QhtYK0Lfmlxa7StfJ5RMhPEjIg6ZYhShudQ5DyRiFOK4E5KZwNcaBWhylURP4KCsSvsMXJlqJRI_ykNFeao81bHhOuQm5gLjG-1A0Isx0x3xONW_KLJmAzxKslYLGWoha7SQMQfebPp8bWk3_tn6hLSzaUmU2c2Dqr7OOg_MRIq_HmWkia1kLEIjNEaliOfoZFucRA4c97rNejPMEBwK2pxnqQOvNq_RA0lHsrTVqm2T0PJ64MDT1hQ2I-lNyQGxZSRbQ91-U958bli-Ueg-T2MH3vbm9GtYfxfF8__-0As4CskP6IhjdAwHy3plX2LAtVQD2BdzMYDD4XByOcH7yXj66QKfjvho0CxiDBo_o-uP8U9UECwn |
linkProvider | Scholars Portal |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Zb9QwEB6VrRC8IG4CBYIETxA1sZ3rAaEWWm1pu0JlK_XN-ApUWpJ2D9D-KX4jM7mq5ehbXxM7csZj-xvPzDcALwu0GhIdpoFICjRQ0ogFKoptIGKuWcwLrS0lJx-OkuGx-HgSn6zBry4XhsIquz2x3qhtZeiOfBNhekpuUpG_OzsPqGoUeVe7EhqNWuy75U802WZv9z7g_L5ibHdn_H4YtFUFAoPoZB4wFzmXstDZQjkT6tBklEaDyAmxtsrx_DSJMkUSKUTnxO6WKmGj0BhEB7bQGcfvXoN1wdGUGcD69s7o01F_qxNyTiCizc4JebY5E5GgPCGGVjtCkywQKydgXSjgX-j27yDNPzy19QG4extutcjV32pU7Q6sufIuXG9qWS7vwfgz9pq4gDwB_tFoK5i5c5_IkCdk_s985VNSJwUm-YbqF5WV-66nS2Lm9c1kQXwN_mnpVz_QeFcltkFtnN6H4ysR7gMYlFXpHoGvcqPTLOQF05T-muQmtolhiY2TFGGT8SDqxChNy2dOZTUmsvar80w2opcoelmLXgoPXvd9zho2j0tbb9Ps9C2Jibt-UE2_ynZhyzTHHU1bZWOnhOCo29bqHM1ECpiLM-7BRje3st0eZvJCmT140b_GhU1zpEpXLZo2Gd3aRx48bFShHwkXRFyYMQ_SFSVZGerqm_L0W00ejkIPkzz24E2nThfD-r8oHl_-F8_hxnB8eCAP9kb7T-AmI22nUEm-AYP5dOGeInCb62ftavHhy1Uv0N8qcVI- |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Zb9QwEB6VIhAviJtAASPBE0SbxE6cPCBUKKuWwgpBK-2b6ytQaUnaPUD71_h1zOTYajn61teNE3nH39jfeC6AZyVaDZmJZCiyEg0UGSehjlMXipSbJOWlMY6Skz-Ost1D8X6cjjfgV58LQ2GV_Z7YbNSutnRHPkCaLslNKopB2YVFfNoZvj45DamDFHla-3YaLUT2_fInmm-zV3s7uNbPk2T47uDtbth1GAgtMpV5mPjYe5lE3pXa28hENqeUGmRRyLt1gWepzbQts1gjU6dKb1ILF0fWIlNwpck5fvcSXJY8jUnH5Fiu7ncizolOdHk6Ec8HMxELyhhK0H5HkpKHYu0sbFoG_Ivn_h2u-YfPtjkKhzfgesdh2XYLupuw4atbcKXtarm8DQdf8K2JD8knwD6PtsOZP2VUFnlCFwEzphmld1KIErPUyaiq_XczXVKNXmYnC6rcwI4rVv9AM15XOAZxOb0Dhxci2ruwWdWVvw9MF9bIPOJlYigRNits6jKbZC7NJBIoG0Dci1HZrrI5NdiYqMbDznPVil6h6FUjeiUCeLF656St63Hu6De0OquRVJO7-aGeflWdiitZ4N5mnHap10JwRLlzpkCDkULn0pwHsNWvreo2ipk6g3UAT1ePUcVpjXTl60U7Jqf7-ziAey0UVjPhgkoY5kkAcg0ka1Ndf1Idf2vKiKPQo6xIA3jZw-lsWv8XxYPz_8UTuIpqqT7sjfYfwrWEwE4xk3wLNufThX-EDG5uHjeqwuDoonXzN0xuVQ4 |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Single-cell+RNA-seq+highlights+a+specific+carcinoembryonic+cluster+in+ovarian+cancer&rft.jtitle=Cell+death+%26+disease&rft.au=Zhao%2C+Hongyu&rft.au=Gao%2C+Yan&rft.au=Miao%2C+Jinwei&rft.au=Chen%2C+Suwen&rft.date=2021-11-13&rft.pub=Nature+Publishing+Group+UK&rft.eissn=2041-4889&rft.volume=12&rft.issue=11&rft_id=info:doi/10.1038%2Fs41419-021-04358-4&rft_id=info%3Apmid%2F34775482&rft.externalDocID=PMC8590695 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2041-4889&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2041-4889&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2041-4889&client=summon |